Antibiotic-resistant bacteria thrive when the drugs kill ‘good’ bacteria in the gut, study shows

Boehringer In­gel­heim has ac­quired Uni­ver­si­ty of Basel spin­out T3 Phar­ma­ceu­ti­cals for 450 mil­lion CHF ($507.4 mil­lion) in an ef­fort to ex­pand its im­muno-on­col­o­gy port­fo­lio with

Al­though Lipocine’s can­di­date may have de­liv­ered “mod­est” weight loss re­sults, the com­pa­ny nonethe­less tout­ed its abil­i­ty to pre­serve mus­cle mass in a mid-stage tri­al. It

American societies endorsed five performance measures in valvular and structural heart disease that may be used for public reporting and pay-for-performance programs. (Circulation: Cardiovascular Quality